Skip to main navigation
Go to Nurix Therapeutics, Inc.  homepage
Nurix Therapeutics, Inc.
  • Inside The Science
    • DEL-AI Discovery Engine
    • Targeted Protein Degradation
    • Resource Library
  • Advancing Our Pipeline
    • Pipeline
    • Clinical Trials
  • Learn About Us
    • Our Story
    • Leadership
    • Partnering
    • Contact Us
  • Work at Nurix
    • Our Culture
    • Explore Jobs
Patients
Patients
Investors & News
Investors & News
Go to Nurix Therapeutics, Inc.  homepage
Nurix Therapeutics, Inc.
  • Inside The Science
    • DEL-AI Discovery Engine
    • Targeted Protein Degradation
    • Resource Library
  • Advancing Our Pipeline
    • Pipeline
    • Clinical Trials
  • Learn About Us
    • Our Story
    • Leadership
    • Partnering
    • Contact Us
  • Work at Nurix
    • Our Culture
    • Explore Jobs

FOR INVESTORS

SEC filing details

  • Overview
  • Press Releases
  • Events
  • Financial Info
  • Stock
  • Governance
  • FAQs

Document Details

Form
DEF 14A
Filing Date
March 27, 2026
Document Date
May 15, 2026
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Nurix Therapeutics, Inc.
Issuer
NURIX THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE
XML - XBRL INSTANCE DOCUMENT
Print Page (opens in new tab)

Print Page

Contact IR (opens in new tab)

Contact IR

RSS (opens in new tab)

RSS

Email Alerts (opens in new tab)

Email Alerts

Go to Nurix Therapeutics, Inc.  homepage

WHERE SCIENCE EXPANDS POSSIBILITIES

Inside The Science

  • DEL-AI Discovery Engine
  • Targeted Protein Degradation
  • Resource Library

Advancing Our Pipeline

  • Pipeline
  • Clinical Trials

Learn About Us

  • Our Story
  • Leadership
  • Partnering
  • Contact Us

Work at Nurix

  • Our Culture
  • Explore Jobs

For Investors

  • News
  • Financial Information
  • Stock Information
  • Corporate Governance
  • FAQs
  • Investor Contact

For Patients

  • Resources

©2026 Nurix Therapeutics, Inc.

Privacy Policy

Terms of Use

Cookie Policy

Privacy Policy

Terms of Use

Cookie Policy